Shockwave Therapy for Foot Pain 2026 | DPM Michigan

Shockwave Therapy for Foot Conditions: Evidence & Success Rate Comparison

Extracorporeal shockwave therapy (ESWT) is not a single protocol — radial pressure wave (RSWT) and focused shockwave (fESWT) deliver fundamentally different energy profiles, and the evidence for each varies by condition. The following table maps the strongest evidence for ESWT in podiatric conditions with head-to-head outcome data where available.

Condition	ESWT Type	Protocol	Success Rate	vs Control / Comparison	Evidence Level	Key Citation
Plantar Fasciitis (Chronic, >6 months)	Focused or radial; both effective	3 sessions × 2,000 shocks at 0.12–0.25 mJ/mm²; weekly; no local anesthetic (reduces efficacy)	60–80% at 12 weeks; 75–85% at 12 months	Superior to sham at 3 months (NNT=3); comparable to corticosteroid injection at 6 months but more durable at 12 months	Level I (multiple RCTs)	Rompe et al. AJSM 2007; Gerdesmeyer et al. AJSM 2008
Insertional Achilles Tendinopathy	Focused preferred for deeper tissue penetration	3–5 sessions × 2,000 shocks; weekly; no anesthetic	60–75% at 4 months; superior to eccentric exercise alone	Rompe 2007: ESWT + eccentric = 82% success vs eccentric alone = 57%	Level I	Rompe et al. AJSM 2007 (insertional)
Mid-Portion Achilles Tendinopathy	Focused or radial	3 sessions × 2,000 shocks; combined with eccentric protocol	65–75% at 3 months when combined with eccentric exercise	Combined ESWT + eccentric > either alone; eccentric alone remains first-line	Level II	Rasmussen et al. 2008
Morton’s Neuroma	Focused (requires precision targeting)	3–5 sessions; US-guided to intermetatarsal space; 0.10–0.20 mJ/mm²	50–65% at 6 months	Inferior to alcohol sclerosing injection at 6 months; but avoids injection risks	Level III	Modeweg et al. 2021
Tibialis Posterior Tendinopathy	Focused	3 sessions weekly; target medial ankle + PTT course	55–70% in Stage I–II PTTD	Limited RCT data; case series evidence	Level III-IV	Emerging evidence only
Calcific Tendinopathy (foot/ankle)	Focused — proven calcium dissolution effect	1–3 sessions; higher energy 0.25–0.35 mJ/mm²; targets calcification directly	60–80% calcification reduction on X-ray at 6 months; pain relief 70–85%	Focused >> radial for calcification dissolution; radial has minimal dissolution effect	Level II	Cacchio et al. 2006
Stress Fracture Prevention	Focused — bone stimulation effect	Off-label; emerging data for delayed unions and stress reaction (not acute fracture)	Accelerated bone healing in delayed unions; not for acute management	Not standard of care; no RCT data for foot stress fractures specifically	Level IV	Off-label use only

Focused vs Radial Shockwave: Clinical Decision Matrix

Many patients receive radial pressure wave therapy labeled as “shockwave” when focused ESWT would be more appropriate for their condition — and vice versa. The two devices deliver fundamentally different physics. Understanding the distinction allows patients to ask the right questions before committing to a treatment series.

Feature	Focused ESWT (fESWT)	Radial Pressure Wave (RSWT)
Energy Generation	Electrohydraulic, electromagnetic, or piezoelectric; precise energy delivery to focal point	Compressed air propels a projectile; creates pressure wave at applicator surface — disperses radially
Penetration Depth	3–12 cm (adjustable focal depth); targets deep structures precisely	Superficial — max 3–4 cm effective; energy dissipates rapidly with depth
Energy Flux Density	0.05–0.50 mJ/mm² (low, medium, high energy protocols)	Lower energy per unit area; cannot achieve high-energy focused delivery
Pain During Treatment	Moderate-significant; correlates with therapeutic effect; local anesthetic REDUCES efficacy	Mild-moderate; more tolerable; less correlation between pain and efficacy
Session Count	3–5 sessions; less frequent	4–6 sessions; more frequent required for equivalent effect
Calcification Dissolution	YES — proven mechanism; high-energy focused waves fragment calcium deposits	Minimal — insufficient energy density for calcium dissolution
Best For	Insertional Achilles, plantar fasciitis, calcific tendinopathy, deep structures (>4 cm)	Mid-portion Achilles, plantar fasciitis (superficial), soft tissue trigger points, general tendinopathy
FDA Status	FDA cleared: plantar fasciitis (chronic), lateral epicondylitis	Not separately FDA cleared in US; marketed as “radial pressure wave therapy”
Cost per Session	$200–400; equipment cost higher	$100–250; equipment more accessible
When to Choose	Calcification present; insertional disease; failed radial treatment; depth >4cm required	Mid-portion tendinopathy without calcification; budget-sensitive; mild-moderate chronic tendinopathy

What Is Extracorporeal Shockwave Therapy?

Extracorporeal shockwave therapy (ESWT) is a non-invasive treatment that delivers focused or radial acoustic pressure waves to chronically injured musculoskeletal tissue. Originally developed to fragment kidney stones (lithotripsy), the technology was adapted for orthopedic applications when clinicians observed that shockwave exposure stimulated bone healing and soft tissue repair. Over the past three decades, ESWT has accumulated a robust evidence base for treating chronic tendinopathies — particularly plantar fasciitis and Achilles tendinopathy — that have failed conventional conservative management.

ESWT is FDA-cleared in the United States for the treatment of chronic plantar fasciitis (1998) and calcific rotator cuff tendinopathy. It has been extensively studied for insertional Achilles tendinopathy, Achilles midportion tendinopathy, patellar tendinopathy, and lateral epicondylitis. In the foot and ankle, plantar fasciitis and insertional Achilles tendinopathy are the primary indications, with calcific tendinopathy responding particularly well.

Mechanisms of Action

The therapeutic mechanisms of ESWT are multifactorial and still being fully elucidated, but several well-documented effects explain its clinical benefit:

Neovascularization: Shockwave energy stimulates the release of vascular endothelial growth factor (VEGF) and nitric oxide, promoting new capillary growth into the hypovascular tendinopathic tissue. The watershed zones of the Achilles tendon and plantar fascia insertion are specifically prone to avascular degeneration; ESWT reverses this by restoring blood supply to the healing zone.

Growth factor activation: ESWT stimulates release of transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), and insulin-like growth factor-1 (IGF-1) — the same growth factors that drive the early reparative phase of tendon healing, reproducing the biological healing cascade that is deficient in chronic tendinopathy.

Calcification disruption: High-energy shockwave specifically disrupts and fragments calcium hydroxyapatite deposits within calcific tendinopathies (insertional Achilles calcium deposits, calcific plantar fasciitis enthesopathy). The fragmented calcium is resorbed through the normal inflammatory-clearance mechanism. This physical disruption mechanism makes ESWT uniquely effective for the calcific subtype of insertional tendinopathy — more so than any injectable therapy.

Neuroplastic pain modulation: ESWT modulates substance P and calcitonin gene-related peptide (CGRP) in sensory nerve fibers within treated tissue, reducing the neurogenic inflammation and central sensitization that perpetuates chronic tendinopathy pain beyond the original tissue injury.

Types of Shockwave Therapy

Two fundamentally different shockwave delivery systems are used in clinical practice. Focused (high-energy) ESWT uses an electrohydraulic, electromagnetic, or piezoelectric generator to produce a focused pressure wave at a precise tissue depth, delivering high peak pressures (50–100 MPa) to a small treatment volume. Focused systems are the technology studied in the original important trials for plantar fasciitis and are particularly effective for calcific tendinopathy. They typically require only 1–3 sessions.

Radial pressure wave therapy (rESWT) uses a pneumatically accelerated projectile to generate a radial pressure wave from the skin surface outward — lower peak pressures distributed over a larger, less focused area. Radial systems are more widely available, less expensive, and well-suited for diffuse tendinopathy without discrete calcification. They typically require 3–5 weekly sessions for equivalent clinical benefit. The distinction between focused and radial ESWT is important for patient education — both are effective, but with different treatment protocols and ideal indications.

Indications for Plantar Fasciitis

ESWT for plantar fasciitis is indicated after failure of 3–6 months of appropriate conservative management — including stretching protocols, custom orthotics, and anti-inflammatory treatment. The landmark randomized controlled trial by Ogden et al. (2001) demonstrated significantly better outcomes than placebo for chronic plantar fasciitis (pain duration >6 months). Meta-analyses consistently show 60–80% good-to-excellent outcomes with ESWT for chronic plantar fasciitis, comparable to surgical plantar fasciotomy outcomes without the risks of surgery or the recovery of an invasive procedure.

Important patient selection: ESWT is most effective for chronic plantar fasciitis (>3–6 months duration) with insertional heel pain. Acute plantar fasciitis (<3 months) typically responds well to conventional conservative care without requiring ESWT. Patients with systemic conditions affecting healing (uncontrolled diabetes, severe vascular disease, coagulation disorders, active infection) are not ideal candidates.

Indications for Achilles Tendinopathy

Insertional Achilles tendinopathy — particularly with calcific deposits — responds exceptionally well to ESWT, with multiple RCTs demonstrating superiority over eccentric exercise alone. For non-insertional (midportion) Achilles tendinopathy, the evidence base is slightly less robust but still supportive of ESWT as a valuable adjunct when eccentric exercise has not achieved adequate relief at 3 months. ESWT allows continuation of athletic training during treatment, unlike surgical options that require significant downtime — a major practical advantage for competitive athletes and active patients.

The Treatment Protocol

At Balance Foot & Ankle, ESWT is delivered with radial pressure wave technology in a series of 3–5 weekly sessions. Each session lasts approximately 20 minutes. The treatment area is identified with ultrasound guidance or clinical palpation, and the shockwave probe is applied through coupling gel. Patients typically experience a deep pressure or aching sensation during treatment — tolerable but noticeable. A temporary pain flare for 24–48 hours after each session is expected as part of the tissue healing response; patients are advised to reduce activity intensity during this period but not to discontinue treatment.

Clinical response typically begins to emerge 4–8 weeks after completing the treatment series as the biological healing processes stimulated by ESWT reach their peak effect. Most patients have not achieved their maximum benefit until 12 weeks post-treatment. Impatience — judging the procedure ineffective at 4 weeks — is a common error. A structured follow-up protocol with clinical reassessment at 6 and 12 weeks post-treatment guides further management decisions.

ESWT vs Surgery vs Injection

For chronic plantar fasciitis, ESWT offers several advantages over alternative treatments. Compared to surgery (plantar fasciotomy), ESWT avoids general/regional anesthesia, post-operative non-weight-bearing, wound complications, and the risk of medial arch destabilization from over-resection of the plantar fascia. Compared to corticosteroid injection, ESWT is biologically regenerative (promotes healing) rather than anti-inflammatory (suppresses healing response) — a critical distinction for chronic tendinopathy where excessive anti-inflammatory treatment can impair tendon repair. Corticosteroid injection provides rapid short-term relief (1–6 weeks) while ESWT provides more sustained long-term benefit (>12 months in most successful cases). In practice, these modalities are often complementary rather than competitive.

Recommended Products to Support Shockwave Therapy

Dr. Tom's Product Recommendations

Frequently Asked Questions

When should I see a podiatrist?

If symptoms persist past 2 weeks, affect your normal activity, or are accompanied by red-flag symptoms (warmth, redness, swelling, inability to bear weight).

What does treatment cost?

Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Out-of-pocket costs vary by your specific plan.

How quickly can I get an appointment?

Most non-urgent cases see us within 5 business days. Urgent cases (sudden pain, possible fracture) typically same or next business day.

What is Foot pain?

Foot pain is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of foot pain include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of foot pain respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

Recovery timeline and prevention

Recovery from foot pain varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.

Visit Balance Foot & Ankle — Same-Day Appointments Available

Our podiatry team serves patients throughout Michigan including Howell, Brighton, and Bloomfield Hills. Whether you’re dealing with heel pain, ingrown toenails, or a foot injury, we have same-day appointment availability.